Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Neurochem Res ; 29(11): 2125-34, 2004 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-15662847

RESUMO

Sodium butyrate (NaBt), a histone deacetylase inhibitor, can cause apoptosis in a number of cancer cells. However, the mechanism of this action is poorly understood. Increased intracellular [Ca(2+)] level has been suggested as a likely mechanism, but there is little corroborating data. In this report we provide evidence that NaBt-treated MSN neuroblastoma cells undergo massive apoptosis in the presence of serum and regardless of external or internal [Ca(2+)] levels. Presented data suggest that apoptotic effect of NaBt is both time- and dose-dependent (LD50 1 mM); and that, presence of serum or cAMP, a second messenger molecule that modulates the apoptotic program in a wide variety of cells could not circumvent the apoptotic effect of NaBt. Our findings suggest that NaBt-induced apoptosis in MSN neuroblastoma cells occurs via a pathway that is independent of Ca(2+) flux, intracellular [Ca(2+)] or cAMP levels. Further, we also present data that exclude a role for PKC or histones acetylation.


Assuntos
Apoptose/efeitos dos fármacos , Neoplasias Encefálicas/patologia , Butiratos/farmacologia , Sinalização do Cálcio/fisiologia , Neuroblastoma/patologia , Bucladesina/farmacologia , Cálcio/metabolismo , Cálcio/farmacologia , Sinalização do Cálcio/efeitos dos fármacos , Linhagem Celular Tumoral , Fragmentação do DNA , Humanos , Inibidores de Fosfodiesterase/farmacologia , Sais de Tetrazólio , Teofilina/farmacologia , Tiazóis
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA